SDC1 and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma (PDAC), serum SDC1 level was remarkably elevated, and receiver operating characteristic (ROC) analysis area under the curve was 0.847 [47], suggesting that serum SDC1 served as a promising novel biomarker for PDAC early diagnosis.